Yi Chen
Stock Analyst at HC Wainwright & Co.
(2.92)
# 1,208
Out of 4,479 analysts
379
Total ratings
30.83%
Success rate
1.83%
Average return
Main Sectors:
43 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EYPT EyePoint Pharmaceuticals | Reiterates: Buy | $30 | $8.31 | +261.01% | 17 | Jun 27, 2024 | |
| DRTS Alpha Tau Medical | Reiterates: Buy | $9 | $2.55 | +252.94% | 12 | Jun 26, 2024 | |
| ALIM Alimera Sciences | Downgrades: Neutral | $6 | $5.52 | +8.70% | 15 | Jun 25, 2024 | |
| RGNX REGENXBIO | Reiterates: Buy | $38 | $11.07 | +243.27% | 3 | Jun 20, 2024 | |
| CODX Co-Diagnostics | Reiterates: Neutral | $2 | $1.26 | +58.73% | 14 | Jun 17, 2024 | |
| OCUL Ocular Therapeutix | Reiterates: Buy | $14 | $6.66 | +110.21% | 17 | Jun 14, 2024 | |
| BLTE Belite Bio | Reiterates: Buy | $59 | $45.82 | +28.76% | 14 | Jun 13, 2024 | |
| OCS Oculis Holding AG | Maintains: Buy | $28 → $30 | $11.89 | +152.31% | 8 | Jun 11, 2024 | |
| APDN Applied DNA Sciences | Maintains: Buy | $7 → $1.5 | $0.55 | +175.23% | 18 | Jun 10, 2024 | |
| ANIX Anixa Biosciences | Maintains: Buy | $12 → $7 | $2.22 | +215.32% | 14 | Jun 10, 2024 | |
| BRNS Barinthus Biotherapeutics | Reiterates: Buy | $8 | $1.43 | +459.44% | 6 | Jun 7, 2024 | |
| ICCM IceCure Medical | Reiterates: Buy | $3 | $0.74 | +308.16% | 14 | Jun 5, 2024 | |
| CDNA CareDx | Reiterates: Neutral | n/a | $15.38 | - | 4 | May 31, 2024 | |
| GLSI Greenwich LifeSciences | Reiterates: Buy | $36 | $16.77 | +114.67% | 5 | May 22, 2024 | |
| ANGO AngioDynamics | Reiterates: Buy | $14 | $5.72 | +144.76% | 4 | May 22, 2024 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $18 | $4.35 | +313.79% | 12 | May 20, 2024 | |
| KALA Kala Pharmaceuticals | Maintains: Buy | $21 → $18 | $6.89 | +161.25% | 16 | May 17, 2024 | |
| GNPX Genprex | Reiterates: Buy | $10 | $1.93 | +418.13% | 5 | May 17, 2024 | |
| TRML Tourmaline Bio | Reiterates: Buy | $48 | $12.74 | +276.77% | 2 | May 14, 2024 | |
| SRTS Sensus Healthcare | Maintains: Buy | $8 → $10 | $4.99 | +100.60% | 12 | May 13, 2024 | |
| CLSD Clearside Biomedical | Maintains: Buy | $6 → $5 | $1.24 | +303.23% | 14 | May 13, 2024 | |
| VERU Veru Inc. | Reiterates: Buy | $3 | $0.88 | +241.41% | 16 | May 13, 2024 | |
| LFMD LifeMD | Reiterates: Buy | $12 | $6.80 | +76.47% | 6 | May 10, 2024 | |
| OPK OPKO Health | Reiterates: Buy | $3 | $1.23 | +143.90% | 7 | May 8, 2024 | |
| ASLN ASLAN Pharmaceuticals | Reiterates: Buy | $9 | $0.30 | +2,900.00% | 17 | May 3, 2024 | |
| BLCO Bausch + Lomb | Reiterates: Buy | $20 | $14.59 | +37.08% | 11 | May 2, 2024 | |
| ZYXI Zynex | Reiterates: Buy | $21 | $8.92 | +135.43% | 12 | May 1, 2024 | |
| OKYO OKYO Pharma | Maintains: Buy | $6 → $7 | $1.24 | +464.52% | 4 | Mar 22, 2024 | |
| MYNZ Mainz Biomed B.V. | Maintains: Buy | $5 → $3 | $0.35 | +769.06% | 9 | Mar 6, 2024 | |
| PRPH ProPhase Labs | Reiterates: Buy | $11 | $4.06 | +170.94% | 14 | Feb 21, 2024 | |
| MOTS Motus GI Holdings | Reiterates: Buy | $38 | $0.05 | +74,900.00% | 9 | Sep 27, 2023 | |
| NMRD Nemaura Medical | Maintains: Buy | $7 → $2.5 | $0.06 | +4,066.67% | 4 | Aug 21, 2023 | |
| OPGN OpGen | Downgrades: Neutral | n/a | $2.50 | - | 6 | Aug 14, 2023 | |
| RNLX Renalytix | Reiterates: Buy | $5 | $0.25 | +1,892.83% | 8 | Jun 30, 2023 | |
| CNTG Centogene | Reiterates: Buy | $1.5 | $0.41 | +265.94% | 8 | Jun 28, 2023 | |
| CHEK Check-Cap | Downgrades: Neutral | n/a | $2.04 | - | 5 | Jun 7, 2023 | |
| BPTH Bio-Path Holdings | Maintains: Buy | $240 → $180 | $1.94 | +9,178.35% | 1 | May 19, 2022 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $58 → $48 | $24.63 | +94.88% | 5 | Apr 22, 2022 | |
| IDXG Interpace Biosciences | Downgrades: Neutral | n/a | $1.05 | - | 4 | Nov 17, 2021 | |
| EYEN Eyenovia | Maintains: Buy | n/a | $0.68 | - | 2 | Apr 1, 2021 | |
| CELC Celcuity | Maintains: Buy | n/a | $16.64 | - | 2 | Feb 17, 2021 | |
| CYDY CytoDyn | Reiterates: Buy | n/a | $0.14 | - | 2 | Apr 28, 2020 | |
| OGEN Oragenics | Downgrades: Neutral | n/a | $1.06 | - | 1 | Apr 16, 2020 |
EyePoint Pharmaceuticals
Jun 27, 2024
Reiterates: Buy
Price Target: $30
Current: $8.31
Upside: +261.01%
Alpha Tau Medical
Jun 26, 2024
Reiterates: Buy
Price Target: $9
Current: $2.55
Upside: +252.94%
Alimera Sciences
Jun 25, 2024
Downgrades: Neutral
Price Target: $6
Current: $5.52
Upside: +8.70%
REGENXBIO
Jun 20, 2024
Reiterates: Buy
Price Target: $38
Current: $11.07
Upside: +243.27%
Co-Diagnostics
Jun 17, 2024
Reiterates: Neutral
Price Target: $2
Current: $1.26
Upside: +58.73%
Ocular Therapeutix
Jun 14, 2024
Reiterates: Buy
Price Target: $14
Current: $6.66
Upside: +110.21%
Belite Bio
Jun 13, 2024
Reiterates: Buy
Price Target: $59
Current: $45.82
Upside: +28.76%
Oculis Holding AG
Jun 11, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $11.89
Upside: +152.31%
Applied DNA Sciences
Jun 10, 2024
Maintains: Buy
Price Target: $7 → $1.5
Current: $0.55
Upside: +175.23%
Anixa Biosciences
Jun 10, 2024
Maintains: Buy
Price Target: $12 → $7
Current: $2.22
Upside: +215.32%
Barinthus Biotherapeutics
Jun 7, 2024
Reiterates: Buy
Price Target: $8
Current: $1.43
Upside: +459.44%
IceCure Medical
Jun 5, 2024
Reiterates: Buy
Price Target: $3
Current: $0.74
Upside: +308.16%
CareDx
May 31, 2024
Reiterates: Neutral
Price Target: n/a
Current: $15.38
Upside: -
Greenwich LifeSciences
May 22, 2024
Reiterates: Buy
Price Target: $36
Current: $16.77
Upside: +114.67%
AngioDynamics
May 22, 2024
Reiterates: Buy
Price Target: $14
Current: $5.72
Upside: +144.76%
Kiora Pharmaceuticals
May 20, 2024
Reiterates: Buy
Price Target: $18
Current: $4.35
Upside: +313.79%
Kala Pharmaceuticals
May 17, 2024
Maintains: Buy
Price Target: $21 → $18
Current: $6.89
Upside: +161.25%
Genprex
May 17, 2024
Reiterates: Buy
Price Target: $10
Current: $1.93
Upside: +418.13%
Tourmaline Bio
May 14, 2024
Reiterates: Buy
Price Target: $48
Current: $12.74
Upside: +276.77%
Sensus Healthcare
May 13, 2024
Maintains: Buy
Price Target: $8 → $10
Current: $4.99
Upside: +100.60%
Clearside Biomedical
May 13, 2024
Maintains: Buy
Price Target: $6 → $5
Current: $1.24
Upside: +303.23%
Veru Inc.
May 13, 2024
Reiterates: Buy
Price Target: $3
Current: $0.88
Upside: +241.41%
LifeMD
May 10, 2024
Reiterates: Buy
Price Target: $12
Current: $6.80
Upside: +76.47%
OPKO Health
May 8, 2024
Reiterates: Buy
Price Target: $3
Current: $1.23
Upside: +143.90%
ASLAN Pharmaceuticals
May 3, 2024
Reiterates: Buy
Price Target: $9
Current: $0.30
Upside: +2,900.00%
Bausch + Lomb
May 2, 2024
Reiterates: Buy
Price Target: $20
Current: $14.59
Upside: +37.08%
Zynex
May 1, 2024
Reiterates: Buy
Price Target: $21
Current: $8.92
Upside: +135.43%
OKYO Pharma
Mar 22, 2024
Maintains: Buy
Price Target: $6 → $7
Current: $1.24
Upside: +464.52%
Mainz Biomed B.V.
Mar 6, 2024
Maintains: Buy
Price Target: $5 → $3
Current: $0.35
Upside: +769.06%
ProPhase Labs
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $4.06
Upside: +170.94%
Motus GI Holdings
Sep 27, 2023
Reiterates: Buy
Price Target: $38
Current: $0.05
Upside: +74,900.00%
Nemaura Medical
Aug 21, 2023
Maintains: Buy
Price Target: $7 → $2.5
Current: $0.06
Upside: +4,066.67%
OpGen
Aug 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.50
Upside: -
Renalytix
Jun 30, 2023
Reiterates: Buy
Price Target: $5
Current: $0.25
Upside: +1,892.83%
Centogene
Jun 28, 2023
Reiterates: Buy
Price Target: $1.5
Current: $0.41
Upside: +265.94%
Check-Cap
Jun 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.04
Upside: -
Bio-Path Holdings
May 19, 2022
Maintains: Buy
Price Target: $240 → $180
Current: $1.94
Upside: +9,178.35%
DENTSPLY SIRONA
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $24.63
Upside: +94.88%
Interpace Biosciences
Nov 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.05
Upside: -
Eyenovia
Apr 1, 2021
Maintains: Buy
Price Target: n/a
Current: $0.68
Upside: -
Celcuity
Feb 17, 2021
Maintains: Buy
Price Target: n/a
Current: $16.64
Upside: -
CytoDyn
Apr 28, 2020
Reiterates: Buy
Price Target: n/a
Current: $0.14
Upside: -
Oragenics
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.06
Upside: -